SocialPicks: The Stock Idea Community

Sign Up | Log In | What is SocialPicks?

Today's Picks

Technology Energy Financial More

73%

CLDA BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: LPTN.OB)

Sector: Technology > Scientific & Technical Instr.

The BioMedReports.com research download section has been updated to include PDFs for two recent research reports written by Griffin Securities for Clinical Data (NASDAQ: CLDA) and Lpath, Inc. (OTC: LPTN.OB). Lpath received a buy rating with a $5 per share 12-month price targe...

Mike Havrilla

(+1.04% risk: conservative)

Comment

N/A

PARD Biotech Stocks - Beware of The Covered Call Trap

Sector: Healthcare > Biotechnology & Drugs

Years ago when I worked in retail brokerage, I knew a broker at another firm, who specialized in pitching covered call plays. He would explain to clients how with covered calls you take your profits upfront and the premium you just collected gives you a nice cushion to the downside. Say you buy...

Ivan Mutaftchiev

(-1.37% risk: conservative)

Comment

73%

PBIO Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife

Sector: Healthcare > Biotechnology & Drugs

Below are three under the radar stocks from the healthcare sector that I have been following for the past 3-6 months which have upcoming catalysts in the form of expected strategic deals, clinical trial results, and other corporate developments. Click here to check out my <font> kaChing....

Mike Havrilla

(+1.04% risk: conservative)

Comment

N/A

ISIS ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity

Shares of Isis Pharmaceuticals ( ISIS ) dropped about 17% on Tuesday, November 17 to close at $11.12, down from a previous close of $13.40. The selloff was a reaction to Isis and partner Genzyme( GENZ )'s presentation for Mipomersen Phase 3 Trials data for treatment of HoFH during at the America...

Ivan Mutaftchiev

(-1.37% risk: conservative)

1 comment

73%

ABIO BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO

On 11/23/09, Transcept Pharma (NASDAQ: TSPT) announced that it is scheduled to meet with the FDA on 1/20/10 to discuss the Complete Response Letter (CRL) regarding the New Drug Application (NDA) for Intermezzo (zolpidem tartrate sublingual tablet). As previously announced, the CRL, received by TSPT ...

Mike Havrilla

(+1.04% risk: conservative)

Comment

73%

NVO Diabetes Care: Global Investing Opportunities

Sector: Healthcare > Biotechnology & Drugs

The <font> American Diabetes Association estimates </font> that there are currently 23.6 million diabetics in the U.S. (7.8% of the total population, including 17.9 million diagnosed cases, 5.7 million undiagnosed, and 57 million pre-diabetics. Diabetes results in an estimated $174 billi...

Mike Havrilla

(+1.04% risk: conservative)

Comment

More Front Page Picks >

Picks from Blogs

BloggingStocks

CTRP HMIN		Two favorites in China travel sector Steven Halpern
KSS SHLD		Cramer on BloggingStocks: This bullish retail story looks like a go... Jim Cramer
LOW		With Lowe's, $20 could be the low stock price for 2010 Joseph Lazzaro
BAX		Baxter (BAX): Bank on blood products Steven Halpern
APC		Anadarko: Well-positioned for the oil/natural gas boom Joseph Lazzaro
ETR		Entergy: Pull-back is buy opportunity Joseph Lazzaro

More BloggingStocks Picks >

SeekingAlpha

NUAN		Nuance Communications: An End to Acquisitive Growth Ketul Kirtikumar
WMT		How Wal-Mart Really Beats Expectations Todd Sullivan
MO		Altria's Last Legal Hurdle Should Be Settled This Fall Todd Sullivan
TRW		Can TRW Automotive Escape the Michigan Mess? The Simplified Investor
CHNG		China Natural Gas: Growth Appears Certain James Kar
UEC		U-turn: Uranium Begins Recovery Phase Christopher Ecclestone

More SeekingAlpha Picks >

Get Daily Alerts in Email/BlackBerry

Get free alerts and recommendations from proven top-performing SocialPicks members

Stocks in the News

LDK 4 analyses

LDK Solar's Growth Potential Offset by Gross Margin Pressure - Paul Cheung (Zacks.com)

Growth Prospects and Depressed Stock Price Make LDK Solar a Buy - Zachary Scheidt (ZachStocks)

Fundamentals Make LDK Solar Look Extremely Undervalued - Trader Mark

CSCO 4 analyses

Cisco Systems Still a Wait and See - Thomas Catino (Ant & Sons)

The Miracle at Cisco - Douglas McIntyre (BloggingStocks)

Analysts Can't Make Up Their Minds on Cisco - Jonathan Kennedy (ClusterStock)

MER 4 analyses

The Merrill Lynch Diet: Starving Shareholders - Zack Miller (BloggingStocks)

Merrill's Deals Have Some Scary Fine Print - Henry Blodget

Merrill Gets Positive Feedback from Analysts Following Recent Deals - Notable Calls

... more »

Most Rated Stocks

Symbol	Company Name	Sentiment
AAPL	Apple Computer Inc
GOOG	Google Inc
MSFT	Microsoft Corp
C	Citigroup Inc
GE	General Electric Company
YHOO	Yahoo! Inc
BAC	Bank of America Corp
GS	Goldman Sachs Group Inc The
RIMM	Research in Motion Ltd
F	Ford Motor Company

Top Rated Stocks by Sector »

Great Calls of the Quarter

34%

SMN UltraShort Basic Materials ProShares +34.75% in 524 days

Taking Ultrashort Basic Materials (SMN) up to 4.1% of fundTaking Ultrashort Oil - Gas (DUG) up to 4.3% of fundThe China news might finally be the catalyst to break the trend - we'll see. This is a market (energy) trading more on emotion and momentum, rather than the underlying fundamentals at this s... ... more »

tradermark

(-6.84% risk: moderate)

Comment

49%

TACT TransAct Technologies Inc. +29.81% in 554 days

TransAct Technologies (TACT) Incorporated engages in the design, development, assembly, and marketing of transaction printers and printer-related services, supplies, and spare parts. It offers transaction printers under the Epic and Ithaca brand names. We are bullish on this microcap stock for severa... ... more »

thecorrectcall

(+0.21% risk: moderate)

Comment

85%

ASBC Associated BancCorp +34.21% in 532 days

Out of total assets of $20.1bn, ASBC has $10.2bn in real estate related loans plus $2.2bn in home equity loans and $1.5bn in mortgage related securities (issued by FNM and other govt agencies). The Bank has a modest BBB+ rating and a market Cap which is 1.5x book value. ASBC has con... ... more »

ferrit

(+32.87% risk: moderate)

6 comments

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.